NCT05160818
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must have had 1-3 brain metastases surgically removed
Exclusions: Patients with leptomeningeal disease; Patients with previous radiation to the brain
https://ClinicalTrials.gov/show/NCT05160818